Presentation TCT 2016 Case #1 Resolution: Did We Close It (?), and Long-term Patient Outcomes Presenter: John D. Carroll, David E. Thaler, Mark Reisman November 01, 2016
Presentation TCT 2016 Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke Presenter: John D. Carroll, David E. Thaler, Mark Reisman November 01, 2016
Presentation TCT 2016 Echocardiographic Assessment of the Atrial Septum Presenter: Lee N. Benson, Ziyad M. Hijazi, Craig E Fleishman November 01, 2016
Presentation TCT 2016 RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler November 01, 2016
Presentation TCT 2016 Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen November 01, 2016
Presentation TCT 2016 Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert November 01, 2016
Presentation TCT 2016 Congenital Heart Disease: PFO, ASD, PDA and Coarctation Presenter: Harsimran Sachdeva Singh, John P. Breinholt October 31, 2016
Presentation TCT 2016 TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE) Presenter: Zahid Amin, Jacqueline Saw, David Hildick-Smith October 31, 2016
Presentation TCT 2016 TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk October 31, 2016
Presentation TCT 2016 TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy October 31, 2016
Presentation TCT 2016 TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco October 31, 2016
Presentation TCT 2016 Case #4: ASD Closure in an Elderly Patient Presenter: Ziyad M. Hijazi, Damien P. Kenny, Matthew A Crystal October 30, 2016
Presentation TCT 2016 Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) Presenter: Horst Sievert October 30, 2016
Presentation TCT 2016 PFO Closure: Rationale, Patient Selection and Outcomes Presenter: Sarah Clarke, Megan M Kennison October 30, 2016
Presentation SOLACI 2016 Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated Presenter: Carlos AC Pedra June 09, 2016
Presentation Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials Presenter: David M. Kent February 22, 2016
Presentation Scripps 2016 Can we identifiy the patient who will benefit from PFO closure? Presenter: John D. Carroll February 04, 2016
Presentation PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question Presenter: Pablo Rengifo October 29, 2015
Presentation TCT 2015 Creation of PFO/ASD in Patients With Pulmonary Hypertension: What Is the Correct Size? Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Clifford J. Kavinsky October 15, 2015
Presentation TCT 2015 RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results Presenter: John D. Carroll, Ioanna Kosmidou October 15, 2015